series-b
Stage
1
Investors
About
Ribometrix discovers and develops small-molecule therapeutics that bind structured RNA using a proprietary platform that maps RNA structures and identifies RNA-targeting ligands for drug discovery.
Explore Ribometrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.